A Safety and Efficacy Study of Xolair in Peanut Allergy

Part of paid clinical trials in Denver, Colorado.

Sponsor
Genentech, Inc.
Study ID
NCT00086606
Phase
PHASE2
Status
Terminated

Conditions

  • Allergy

Eligibility Criteria

Sex
ALL
Age
6 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This is a 38-week, randomized, double-blind, placebo-controlled, parallel group trial of approximately 150 patients who have a history of immediate hypersensitivity reaction to peanut protein.

Key Dates

Start date
Jun 30, 2004
Status verified
Jan 2013
Completion
Apr 30, 2006

Study Design

Enrollment
150 participants
Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Trial Information Support LineDenverColorado80012-

Find similar trials in Denver, CO

By research site
Trial Information Support Line· Denver, CO

Related Studies